Immatics N.V. (NASDAQ: IMTX) Stock Information | RedChip

Immatics N.V. (NASDAQ: IMTX) Listen to this Section

$11.51
+0.0100 ( +0.09% ) 175.1K

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Market Data

Open

$11.51

Previous close

$11.50

Volume

175.1K

Market cap

$1.19B

Day range

$11.39 - $11.67

52 week range

$7.15 - $13.77

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings

Form Type Description Pages Date
6-k Quarterly Reports 78 Aug 13, 2024
6-k Quarterly Reports 1 Jul 31, 2024
6-k Quarterly Reports 2 Jun 20, 2024
6-k Quarterly Reports 7 Jun 03, 2024
6-k Quarterly Reports 75 May 14, 2024
20-f Annual reports 155 Mar 21, 2024
6-k Quarterly Reports 78 Mar 21, 2024
6-k Quarterly Reports 83 Jan 22, 2024
6-k Quarterly Reports 4 Nov 14, 2023
6-k Quarterly Reports 141 Nov 08, 2023

Latest News

Terms and Agreement

Please agree to the terms to continue using the chat feature.

About US

Services

Stay Connected